| 发明名称 |
PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO |
| 摘要 |
Novel dry powder compositions comprising and methods relating thereto are provided. The dry powder compositions comprise PDE5 inhibitors, such as vardenafil, or pharmaceutically acceptable salts or esters thereof. The dry powder compositions may optionally include an carrier/excipient. The concentration of active agent may be at least about 2% by weight. Methods of aerosolizing the dry powder compositions and using them to treat various diseases are also disclosed. |
| 申请公布号 |
US2016317542(A1) |
申请公布日期 |
2016.11.03 |
| 申请号 |
US201415102957 |
申请日期 |
2014.12.09 |
| 申请人 |
RESPIRA THERAPEUTICS, INC. |
发明人 |
Xu Zhen;Smyth Hugh;Gibbons Aileen;Shreeniwas Revati;Soni Pravin;Deaton Dan;Hannon James;Lermer Stephen;Curtis Robert |
| 分类号 |
A61K31/53;A61K47/26;A61M15/00;A61K9/00 |
主分类号 |
A61K31/53 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A powder pharmaceutical composition comprising a) at least about 2% by weight of a PDE5 inhibitor or a pharmaceutically acceptable salt or ester thereof relative to the total weight of the overall pharmaceutical composition, and b) at least one pharmaceutically acceptable carrier. |
| 地址 |
Albuquerque NM US |
